Key result
Convalescent serum is inefficacious in the treatment of preparalytic poliomyelitis because the virus exclusively infects the central nervous system.
Convalescent serum is ineffective for preparalytic poliomyelitis because the virus is fixed in the central nervous system.
Answers are grounded in this paper and cite their sources.
Convalescent serum should not be used for preparalytic poliomyelitis; leaves open CNS-targeted antiviral strategies in neurotropic infections.
Controlled clinical and experimental studies have shown that convalescent serum is inefficacious in the treatment of preparalytic poliomyelitis.1The reason for this can be seen from the pathogenesis of the disease, which indicates that poliomyelitis is an infection of the central nervous system exclusively. Evidence has been brought forth to show that the virus of poliomyelitis travels by way of the nerve tracts2and becomes fixed to the anterior horn cells of the spinal cord.3With this fact in mind, and knowing that the central nervous system is a well insulated and closed system, we believe it unlikely that serum could reach the affected cells, and, if it did, it is even more unlikely that it could dislodge the virus.4With the consideration that convalescent serum is of little or no value and that isolation to prevent contact infection is impracticable because of the probable high
No takes yet. Share an insight, caveat, or question.
Maurice Brodie (1935) studied Poliomyelitis. Convalescent serum was evaluated. Convalescent serum is inefficacious in the treatment of preparalytic poliomyelitis because the virus exclusively infects the central nervous system.
Synapse has enriched 10 related papers. Consider them for comparative context: